NR2B negative allosteric modulators (BioCrea)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNR2B negative allosteric modulators (BioCrea)
Drug Alias NameNMDA-receptor positive and negative allosteric modulators (BioCrea)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 modulators
TargetsGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsSchizophreniaDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioCrea GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioCrea GmbH
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepression

Other Information

ATC CodeN/A
Related LinksN/A